Chu, Chia-Yu
Chan, Yung
Wananukul, Siriwan
Cheng, Hao
Chandran, Nisha Suyien
Bhat, Ramesh
Son, Sang Wook
Liao, Han-Fang
Gardiner, Sean http://orcid.org/0009-0008-9193-9844
Yeo, See-Hwee http://orcid.org/0000-0001-8658-8172
Chen, Sophie Bozhi http://orcid.org/0000-0003-2874-1786
Ng, Qi Qing http://orcid.org/0009-0005-6929-665X
Kataoka, Yoko
Funding for this research was provided by:
Pfizer Hong Kong
Article History
Received: 27 May 2024
Accepted: 3 July 2024
First Online: 15 July 2024
Declarations
:
: H.-F.L. and S.G. are employees of Pfizer. Y.K. has received lecturer honoraria from Sanofi, AbbVie, Pfizer, and Maruho and research funding from Sanofi, Leo Pharma, Pfizer, Maruho, Lilly, AbbVie, Otsuka, Taiho, and Amgen. Y.C. is a speaker for AbbVie, Bioderma, Galderma, Inova, Eli Lily, Lumenis, Menarini, and Pfizer; an advisory board member for AbbVie, Bayer, Bioderma, CeraVe, Eli Lilly, Menarini, Pfizer, Sanofi, Quanta System, and Janssen. C.-Y.C. is an investigator for AbbVie, Amgen, Dermira, Eli Lilly, Janssen, Novartis, Oneness Biotech, Pfizer, Regeneron Pharmaceuticals Inc., Roche, and Sanofi; a consultant for AbbVie, Amgen, Eli Lilly, GlaxoSmithKline, Janssen, Novartis, Pfizer, Roche, and Sanofi; a speaker for AbbVie, Eli Lilly, GlaxoSmithKline, Janssen, Mylan, Novartis, Pfizer, Roche, Sanofi, and Viatris; and an advisory board member for AbbVie, Amgen, Mylan, Pfizer, Roche, Sanofi, and Viatris. All other authors have no conflict of interest. Nisha Suyien Chandran has received fees for participation in advisory boards from AbbVie, Johnson and Johnson, Sanofi, Pfizer, DKSH, L’Oreal, and Novartis; investigator fees for clinical trials from AbbVie, Novartis, Amgen, Sanofi, and Boehringer Ingelheim; and speaker honoraria from Galderma, Johnson and Johnson, LEO, Pfizer, Sanofi, and Lion Corporation.
: Ethical approval was received from the following IRBs: Korea University Ansan Hospital, Chulalongkorn University, Father Muller Hospital, NPO MINS, National Taiwan University Hospital, Hong Kong Doctor Union, and Sir Run Run Shaw Hospital. The Parkway Independent Ethics Committee granted an exemption from review. The study was conducted in accordance with the protocol, Guidelines for Good Pharmacoepidemiology Practices, and the Declaration of Helsinki. All participants provided informed consent.